Looks very early stage, doesn't it and not overly attractive. Not an awfully demanding EV but rule of thumb for me with bio IPOs is to expense a large portion of funds raised from day dot, as they'll be gone in the first year. This is going to need a number of CR to get to a stage where it commands a $30m EV or so.
I had thought that Leedman as Chairman might draw the RAP crowd in but I think I'd rather just buy ANP, DXB, PTX or FTT at their current mc and much, much closer to binary events.
NSB, page-3
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.639M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 214285 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 75583 | 1 |
View Market Depth
| Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
| NSB (ASX) Chart |
Day chart unavailable
